Tso; J. Yun
Patent Applications and Registrations
Patent applications and USPTO patent grants for Tso; J. Yun.The latest application filed is for "bifunctional molecules for treatment of immune disorders".
Company Profile
11.58.66
- Tso; J. Yun - Menlo Park CA
- TSO; J. Yun - Mountain View CA
Patent Activity
| Patent | Date |
|---|---|
| Bifunctional Molecules For Treatment Of Immune Disorders App 20220306753 - Tsurushita; Naoya ; et al. | 2022-09-29 |
| Bispecific Antibodies for Activation of Immune Cells App 20220251214 - Tsurushita; Naoya ; et al. | 2022-08-11 |
| Bispecific antibodies which bind PD-L1 and GITR Grant 11,332,532 - Tsurushita , et al. May 17, 2 | 2022-05-17 |
| Multimeric Hybrid Fc Proteins for Replacement of IVIG App 20220002361 - TSURUSHITA; Naoya ; et al. | 2022-01-06 |
| Anti-OX40 antibodies and methods of using the same Grant 10,851,173 - Liu , et al. December 1, 2 | 2020-12-01 |
| Antibodies to TIGIT App 20200297844 - Tso; J. Yun ; et al. | 2020-09-24 |
| Bispecific Antibodies for Activation of Immune Cells App 20200165341 - Tsurushita; Naoya ; et al. | 2020-05-28 |
| Dac Hyp Compositions And Methods App 20200157230 - HARTMAN; Taymar E. ; et al. | 2020-05-21 |
| Therapeutic Use Of Anti-cs1 Antibodies App 20200031929 - WILLIAMS; Marna ; et al. | 2020-01-30 |
| Antibodies to TIGIT Grant 10,537,633 - Tso , et al. Ja | 2020-01-21 |
| Therapeutic use of anti-CS1 antibodies Grant 10,442,859 - Williams , et al. Oc | 2019-10-15 |
| Anti-ox40 Antibodies And Methods Of Using The Same App 20190100596 - LIU; Yong-Jun ; et al. | 2019-04-04 |
| Vectors and host cells comprising a modified SV40 promoter for protein expression App 20190062797 - Hartman; Taymar E. ; et al. | 2019-02-28 |
| Anti-OX40 antibodies and methods of using the same Grant 10,196,450 - Liu , et al. Fe | 2019-02-05 |
| Hybrid constant regions Grant 10,053,517 - Tso , et al. August 21, 2 | 2018-08-21 |
| Vectors and host cells comprising a modified SV40 promoter for protein expression Grant 10,053,720 - Hartman , et al. August 21, 2 | 2018-08-21 |
| Dac Hyp Compositions And Methods App 20180127506 - HARTMAN; Taymar E. ; et al. | 2018-05-10 |
| DAC HYP compositions Grant 9,815,903 - Hartman , et al. November 14, 2 | 2017-11-14 |
| Antibodies To Tigit App 20170281764 - Tso; J. Yun ; et al. | 2017-10-05 |
| Anti-ox40 Antibodies And Methods Of Using The Same App 20170267773 - LIU; Yong-Jun ; et al. | 2017-09-21 |
| Dac Hyp Compositions App 20170247461 - HARTMAN; Taymar E. ; et al. | 2017-08-31 |
| Anti-OX40 antibodies and methods of using the same Grant 9,695,246 - Liu , et al. July 4, 2 | 2017-07-04 |
| DAC HYP compositions and methods Grant 9,676,860 - Hartman , et al. June 13, 2 | 2017-06-13 |
| Antibodies or fusion proteins multimerized via cysteine mutation and a mu tailpiece Grant 9,540,442 - Tsurushita , et al. January 10, 2 | 2017-01-10 |
| Nucleic acid encoding anti-OX40 antibodies Grant 9,527,917 - Liu , et al. December 27, 2 | 2016-12-27 |
| Hybrid Constant Regions App 20160369012 - Tso; J. Yun ; et al. | 2016-12-22 |
| Vectors And Host Cells Comprising A Modified Sv40 Promoter For Protein Expression App 20160265018 - HARTMAN; TAYMAR E. ; et al. | 2016-09-15 |
| Hybrid constant regions Grant 9,382,319 - Tso , et al. July 5, 2 | 2016-07-05 |
| DAC HYP compositions and methods Grant 9,340,619 - Hartman , et al. May 17, 2 | 2016-05-17 |
| Anti-ox40 Antibodies And Methods Of Using The Same App 20160068604 - LIU; Yong-Jun ; et al. | 2016-03-10 |
| DAC HYP compositions and methods Grant 9,260,528 - Hartman , et al. February 16, 2 | 2016-02-16 |
| Therapeutic Use Of Anti-cs1 Antibodies App 20160002335 - WILLIAMS; Marna ; et al. | 2016-01-07 |
| Antibodies That Bind Membrane-bound Il1rap App 20150315279 - JIANG; Ying-Ping ; et al. | 2015-11-05 |
| Anti-ox40 Antibodies And Methods Of Using The Same App 20150315281 - LIU; Yong-Jun ; et al. | 2015-11-05 |
| Therapeutic use of anti-CS1 antibodies Grant 9,175,081 - Williams , et al. November 3, 2 | 2015-11-03 |
| Anti-OX40 antibodies and methods of treating cancer Grant 9,163,085 - Liu , et al. October 20, 2 | 2015-10-20 |
| Dac Hyp Compositions And Methods App 20150274832 - HARTMAN; Taymar E. ; et al. | 2015-10-01 |
| Dac Hyp Compositions And Methods App 20150203583 - HARTMAN; Taymar E. ; et al. | 2015-07-23 |
| Dac Hyp Compositions And Methods App 20150197573 - HARTMAN; Taymar E. ; et al. | 2015-07-16 |
| Antibodies to CD122 Grant 9,028,830 - Tso , et al. May 12, 2 | 2015-05-12 |
| Anti-OX40 antibodies and methods of using the same Grant 9,006,399 - Liu , et al. April 14, 2 | 2015-04-14 |
| Hybrid Constant Regions App 20150073130 - Tso; J. Yun ; et al. | 2015-03-12 |
| Expression vectors Grant 8,969,539 - Tsurushita , et al. March 3, 2 | 2015-03-03 |
| Hybrid constant regions Grant 8,952,134 - Tso , et al. February 10, 2 | 2015-02-10 |
| Antibodies Or Fusion Proteins Multimerized Via Homomultimerizing Peptide App 20150038682 - Tsurushita; Naoya ; et al. | 2015-02-05 |
| Anti-human Sema4a Antibodies Useful To Treat Disease App 20150004178 - Liu; Yong-Jun ; et al. | 2015-01-01 |
| Anti-ox40 Antibodies And Methods Of Using The Same App 20140308276 - Liu; Yong-Jun ; et al. | 2014-10-16 |
| Anti-pleiotrophin Antibodies And Methods Of Use Thereof App 20140294845 - Tso; J. Yun ; et al. | 2014-10-02 |
| Vectors And Host Cells Comprising A Modified Sv40 Promoter For Protein Expression App 20140295497 - Hartman; Taymar E. ; et al. | 2014-10-02 |
| Hybrid Constant Regions App 20140294825 - Tso; J. Yun ; et al. | 2014-10-02 |
| Humanized anti-.alpha. 9 integrin antibodies and the uses thereof Grant 8,821,863 - Kumar , et al. September 2, 2 | 2014-09-02 |
| Generation, expression and characterization of the humanized K33N monoclonal antibody Grant 8,735,552 - Kumar , et al. May 27, 2 | 2014-05-27 |
| Therapeutic Use Of Anti-cs1 Antibodies App 20140065063 - Williams; Marna ; et al. | 2014-03-06 |
| Antibodies Or Fusion Proteins Multimerized Via Cysteine Mutation And A Mu Tailpiece App 20140037621 - Tsurushita; Naoya ; et al. | 2014-02-06 |
| Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof Grant 8,617,829 - Kumar , et al. December 31, 2 | 2013-12-31 |
| Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof Grant 8,614,296 - Kumar , et al. December 24, 2 | 2013-12-24 |
| Anti-ox40 Antibodies And Methods Of Using The Same App 20130280275 - Liu; Yong-Jun ; et al. | 2013-10-24 |
| Therapeutic use of anti-CS1 antibodies Grant 8,461,306 - Williams , et al. June 11, 2 | 2013-06-11 |
| Therapeutic use of anti-CS1 antibodies Grant 8,445,646 - Williams , et al. May 21, 2 | 2013-05-21 |
| Therapeutic use of anti-CS1 antibodies Grant 8,444,980 - Williams , et al. May 21, 2 | 2013-05-21 |
| Therapeutic use of anti-CS1 antibodies Grant 8,436,146 - Williams , et al. May 7, 2 | 2013-05-07 |
| Hybrid Constant Regions App 20130089547 - Tso; J. Yun ; et al. | 2013-04-11 |
| Therapeutic use of anti-CS1 antibodies Grant 8,349,330 - Williams , et al. January 8, 2 | 2013-01-08 |
| Dac Hyp Compositions And Methods App 20120301429 - HARTMAN; Taymar E. ; et al. | 2012-11-29 |
| Therapeutic Use Of Anti-cs1 Antibodies App 20120070440 - Williams; Marna ; et al. | 2012-03-22 |
| Therapeutic Use Of Anti-cs1 Antibodies App 20120064068 - Williams; Marna ; et al. | 2012-03-15 |
| Therapeutic Use Of Anti-cs1 Antibodies App 20120064067 - Williams; Marna ; et al. | 2012-03-15 |
| Therapeutic Use Of Anti-cs1 Antibodies App 20120064083 - Williams; Marna ; et al. | 2012-03-15 |
| Therapeutic Use Of Anti-cs1 Antibodies App 20120064069 - WILLIAMS; Marna ; et al. | 2012-03-15 |
| Therapeutic use of anti-CS1 antibodies Grant 8,133,981 - Williams , et al. March 13, 2 | 2012-03-13 |
| Therapeutic use of anti-CS1 antibodies Grant 8,088,898 - Williams , et al. January 3, 2 | 2012-01-03 |
| Generation, Expression And Characterization Of The Humanized K33n Monoclonal Antibody App 20110300139 - Kumar; Shankar ; et al. | 2011-12-08 |
| Antibodies To Cd122 App 20110250213 - Tso; J. Yun ; et al. | 2011-10-13 |
| Anti-hDlk-1 antibody having an antitumor activity in vivo Grant 8,017,118 - Nakamura , et al. September 13, 2 | 2011-09-13 |
| Therapeutic use of anti-CS1 antibodies Grant 8,008,450 - Williams , et al. August 30, 2 | 2011-08-30 |
| Anti-pleiotrophin Antibodies And Methods Of Use Thereof App 20110182890 - Tso; J. Yun ; et al. | 2011-07-28 |
| Humanized Antibodies Specific For Amino Acid Sequence Rgd Of An Extracellular Matrix Protein And The Uses Thereof App 20110091386 - Kumar; Shankar ; et al. | 2011-04-21 |
| Anti-pleiotrophin antibodies and methods of use thereof Grant 7,888,485 - Tso , et al. February 15, 2 | 2011-02-15 |
| Humanized Anti-alpha 9 Integrin Antibodies And The Uses Thereof App 20100329980 - Kumar; Shankar ; et al. | 2010-12-30 |
| Therapeutic Use Of Anti-cs1 Antibodies App 20100168397 - Williams; Marna ; et al. | 2010-07-01 |
| Therapeutic use of anti-CS1 antibodies Grant 7,709,610 - Williams , et al. May 4, 2 | 2010-05-04 |
| Expression vectors App 20090320149 - Tsurushita; Naoya ; et al. | 2009-12-24 |
| Anti-hdlk-1 Antibody Having An Antitumor Activity In Vivo App 20090299038 - Nakamura; Koji ; et al. | 2009-12-03 |
| Therapeutic Use Of Anti-cs1 Antibodies App 20090246852 - Williams; Marna ; et al. | 2009-10-01 |
| Therapeutic Use Of Anti-cs1 Antibodies App 20090238827 - WILLIAMS; MARNA ; et al. | 2009-09-24 |
| Therapeutic Use Of Anti-cs1 Antibodies App 20090238835 - Williams; Marna ; et al. | 2009-09-24 |
| Humanized antibodies against CD3 Grant 7,381,803 - Weiner , et al. June 3, 2 | 2008-06-03 |
| Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis Grant 7,365,168 - Hinton , et al. April 29, 2 | 2008-04-29 |
| Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis Grant 7,361,740 - Hinton , et al. April 22, 2 | 2008-04-22 |
| Humanized Antibodies Against Cd3 App 20080025975 - Weiner; George ; et al. | 2008-01-31 |
| Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis Grant 7,217,797 - Hinton , et al. May 15, 2 | 2007-05-15 |
| Therapeutic use of anti-CS1 antibodies App 20060024296 - Williams; Marna ; et al. | 2006-02-02 |
| Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis App 20050276799 - Hinton, Paul R. ; et al. | 2005-12-15 |
| Anti-HLA-DA antibodies and the methods of using thereof Grant 6,894,149 - Tso , et al. May 17, 2 | 2005-05-17 |
| Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis App 20050032114 - Hinton, Paul R. ; et al. | 2005-02-10 |
| Therapeutic use of anti-CS1 antibodies App 20050025763 - Williams, Marna ; et al. | 2005-02-03 |
| Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis App 20050014934 - Hinton, Paul R. ; et al. | 2005-01-20 |
| Anti-pleiotrophin antibodies and methods of use thereof App 20040234519 - Tso, J. Yun ; et al. | 2004-11-25 |
| Humanized antibodies against CD3 App 20040052783 - Weiner, George ; et al. | 2004-03-18 |
| Anti-HLA-DR antibodies and the methods of using thereof App 20030138862 - Tso, J. Yun ; et al. | 2003-07-24 |
| Identifying anti-tumor targets or agents by lipid raft immunization and proteomics App 20030096285 - Tso, J. Yun ; et al. | 2003-05-22 |
| Treatment of prostate cancer by inhibitors of ATP synthase App 20030086929 - Tso, J. Yun ; et al. | 2003-05-08 |
| Treatment of prostate cancer by inhibitors of NCAM2 App 20030082188 - Tso, J. Yun ; et al. | 2003-05-01 |
| Bispecific antibody effective to treat B-cell lymphoma and cell line Grant 6,129,914 - Weiner , et al. October 10, 2 | 2000-10-10 |
| Bispecific antibody heterodimers Grant 5,932,448 - Tso , et al. August 3, 1 | 1999-08-03 |
| Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same Grant 5,834,597 - Tso , et al. November 10, 1 | 1998-11-10 |
| Humanized antibodies reactive with GPIIB/IIIA Grant 5,777,085 - Co , et al. July 7, 1 | 1998-07-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 